![Nicholas G. Galakatos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas G. Galakatos
Corporate Officer/Principal at BLACKSTONE INC.
Profile
Nicholas G.
Galakatos founded TransForm Pharmaceuticals, Inc. in 1999, where he is working as Chairman & Chief Executive Officer from 1999 and Clarus Ventures LLC in 2005, where he worked as Managing Director from 2005 to 2018.
Dr. Galakatos also founded Millennium Predictive Medicine, Inc. Dr. Galakatos also currently works at Anthos Therapeutics, Inc., as Chairman from 2019, BioMed Realty LP, as Director, David H.
Koch Institute for Integrative Cancer Research, as Member-Director Council, and various other companies.
Dr. Galakatos also formerly worked at Hypnion, Inc., as Chairman, Syrrx, Inc., as Director, Critical Therapeutics, Inc., as Director in 2015, and various other companies.
Dr. Galakatos received his undergraduate degree from The Reed Institute and doctorate degree from Massachusetts Institute of Technology.
Latest news about Nicholas G. Galakatos
Nicholas G. Galakatos active positions
| Companies | Position | Start |
|---|---|---|
| BLACKSTONE INC. | Corporate Officer/Principal | - |
David H. Koch Institute for Integrative Cancer Research
 David H. Koch Institute for Integrative Cancer Research Operates as cancer research center | Corporate Officer/Principal | - |
Nuvelution Pharma, Inc.
 Nuvelution Pharma, Inc. Provides solutions for R&D companies in the pharmaceutical and biotech industries | Director/Board Member | - |
MPM Asset Management II LLC | Corporate Officer/Principal | 31/12/1999 |
Anthos Therapeutics, Inc.
 Anthos Therapeutics, Inc. Develops and markets genetically and pharmacologically validated therapies for high-risk cardiovascular patient populations | Chairman | 31/12/2018 |
The Reed Institute
 The Reed Institute Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | - |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Blackstone Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields on pharmaceutical, biotechnology and medical technology sectors. It provides financing for growth stage transactions. | Chairman | 30/11/2018 |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Develops and manufactures drugs for infectious diseases | Director/Board Member | 23/06/2019 |
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Chief Executive Officer | 31/12/1998 |
| ░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Nicholas G. Galakatos
| Companies | Position | End |
|---|---|---|
| ░░░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░ ░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Training of Nicholas G. Galakatos
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 38 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology treatment products | Health Technology |
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Finance |
Syrrx, Inc.
 Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
Hypnion, Inc.
 Hypnion, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops neuroscience drugs | Commercial Services |
MPM BioVentures III GP LP | |
Critical Therapeutics, Inc.
 Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Health Technology |
MPM Asset Management II LLC | |
Aerovance, Inc.
 Aerovance, Inc. Medical DistributorsDistribution Services Develops drugs for respiratory and inflammatory diseases | Distribution Services |
BioMed Realty LP
 BioMed Realty LP Real Estate Investment TrustsFinance Provides real estates services | Finance |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutic products | Health Technology |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Link Medicine Corp.
 Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Develops disease modifying neurodegenerative therapies | Health Technology |
Taligen Therapeutics, Inc.
 Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops inflammatory disease pharamaceutical products | Health Technology |
Alinea Pharmaceuticals, Inc.
 Alinea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for diabetes and related metabolic disorders | Health Technology |
Astria Therapeutics, Inc.
 Astria Therapeutics, Inc. Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Affymax, Inc.
 Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
The Reed Institute
The Reed Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
NS Wind Down Co., Inc.
 NS Wind Down Co., Inc. BiotechnologyHealth Technology Develops and manufactures life science tools for translational research and molecular diagnostic products | Health Technology |
Caliper Technologies Corp.
 Caliper Technologies Corp. Medical SpecialtiesHealth Technology A leading provider of microfluidic technology and laboratory automation solutions serving a broad range of markets in the worldwide life science, biotechnology and pharmaceutical industries. | Health Technology |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of biopharmaceutical and medical technology. It participates in early stage capital transactions. Clarus Ventures acquired by Blackstone Inc on November 30, 2018. Clarus ventures will become Blackstone Life Sciences. | Finance |
Blackstone, Inc.
 Blackstone, Inc. Investment ManagersFinance Provides investment and fund management services | Finance |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology Manufactures and sells gene therapy products to treat diseases of the eye | Health Technology |
Millennium Biotherapeutics, Inc. | |
Millennium Predictive Medicine, Inc. | |
Cornerstone Therapeutics, Inc.
 Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, acquires and markets specialty pharmaceutical products for hospitals & related specialty markets | Health Technology |
David H. Koch Institute for Integrative Cancer Research
David H. Koch Institute for Integrative Cancer Research Operates as cancer research center | |
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Operates as a biopharmaceutical company | |
Nuvelution Pharma, Inc.
Nuvelution Pharma, Inc. Provides solutions for R&D companies in the pharmaceutical and biotech industries | |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Develops and manufactures drugs for infectious diseases | |
Praxis Precision Medicines, Inc.
 Praxis Precision Medicines, Inc. Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | |
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. Engages in discovering and developing antibacterial therapeutics | |
Blackstone Life Sciences Advisors LLC
Blackstone Life Sciences Advisors LLC Blackstone Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields on pharmaceutical, biotechnology and medical technology sectors. It provides financing for growth stage transactions. | |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. Develops and markets genetically and pharmacologically validated therapies for high-risk cardiovascular patient populations |
- Stock Market
- Insiders
- Nicholas G. Galakatos
